Home

Gabrielle Sulzberger

CIK 1262388 · last filed 2026-08-18

Gabrielle Sulzberger is a corporate insider who has filed 129 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing shows the insider was granted $5.0K of LLY on Aug 18, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.0M across reported positions. 59 SEC filings were submitted jointly with LILLY & Co ELI.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.97M

Companies

12

Total Filings

129

Lifetime Open-Market Net

-$2.80M

Filer Profile

Reported Address
450 LEXINGTON AVENUE, FLOOR 13
NEW YORK, NY 10017
Formerly Known As
Greene-Sulzberger Gabrielle (2014–2020)
GREENE GABRIELLE E (2003–2014)
Related Filers
LILLY & Co ELI — 59 joint filings, latest 2026-08-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LLY Director 3,003 $1149.36 $3.45M $75.0K 58 2026-08-18
MA Director 5,845 $579.21 $3.39M $0 9 2026-06-18
WRBY Director 84,024 $24.35 $2.05M -$1.09M 5 2024-06-11
Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Director 58,876 $44.96 $2.65M $0 4 2024-06-07
Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted Director 49,624 $18.07 $896.7K $275.4K 3 2021-06-24
BRX Director 37,161 $29.15 $1.08M $36.6K 8 2021-06-01
WHOLE FOODS MARKET INC (WFM) Delisted Director 0 — — -$1.33M 21 2017-08-28
STAGE STORES INC (SSI) Delisted Director 21,574 — — $0 3 2013-06-17
WHOLE FOODS MARKET INC (WFMI) Delisted Director 4,829 — — -$767.1K 11 2011-02-11
BRIGHT HORIZONS FAMILY SOLUTIONS INC (GGA) Delisted Director — — — $0 1 2008-05-28
INDYMAC BANCORP INC (IMB) Delisted 4,443 — — $8.1K 1 2008-03-19
INDYMAC BANCORP INC (NDE) Delisted 2,828 — — $0 2 2007-03-27

Recent Filings

129 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-18 LLY Grant (A) +4 $5.0K EDGAR
2026-07-21 LLY Grant (A) +4 $5.0K EDGAR
2026-06-18 MA Grant (A) +509 $0 EDGAR
2026-06-16 LLY Grant (A) +4 $5.0K EDGAR
2026-05-19 LLY Grant (A) +5 $5.0K EDGAR
2026-04-21 LLY Grant (A) +5 $5.0K EDGAR
2026-03-17 LLY Grant (A) +5 $5.0K EDGAR
2026-02-18 LLY Grant (A) +4 $5.0K EDGAR
2026-01-21 LLY Grant (A) +4 $5.0K EDGAR
2025-12-16 LLY Grant (A) +4 $5.0K EDGAR
Showing 1–10 of 129
Page 1 of 13
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.